ATE557006T1 - 4-hydroxybenzomorphane - Google Patents

4-hydroxybenzomorphane

Info

Publication number: ATE557006T1
Authority: AT; Austria
Prior art keywords: hydroxybenzomorphanes; hydroxybenzomorphans; thiocarboxamide; antitussives; anticonvulsants
Prior art date: 2004-11-05

Application number

AT10008474T

Other languages

English (en)

Inventor

Mark P Wentland

Original Assignee

Rensselaer Polytech Inst

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-11-05

Filing date

2005-11-03

Publication date

2012-05-15

2005-11-03 Application filed by Rensselaer Polytech Inst filed Critical Rensselaer Polytech Inst

2012-05-15 Application granted granted Critical

2012-05-15 Publication of ATE557006T1 publication Critical patent/ATE557006T1/de

Links

206010012335 Dependence Diseases 0.000 abstract 1
229940035676 analgesics Drugs 0.000 abstract 1
230000000954 anitussive effect Effects 0.000 abstract 1
239000000730 antalgic agent Substances 0.000 abstract 1
229940125681 anticonvulsant agent Drugs 0.000 abstract 1
239000001961 anticonvulsive agent Substances 0.000 abstract 1
229940125714 antidiarrheal agent Drugs 0.000 abstract 1
239000003793 antidiarrheal agent Substances 0.000 abstract 1
239000003434 antitussive agent Substances 0.000 abstract 1
229940124584 antitussives Drugs 0.000 abstract 1
125000003917 carbamoyl group Chemical class [H]N([H])C(*)=O 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000002483 medication Methods 0.000 abstract 1
CYEBJEDOHLIWNP-UHFFFAOYSA-N methanethioamide Chemical compound NC=S CYEBJEDOHLIWNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/26—Benzomorphans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Immunology (AREA)
Pulmonology (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Child & Adolescent Psychology (AREA)
Obesity (AREA)
Transplantation (AREA)
Dermatology (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Hematology (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Hydrogenated Pyridines (AREA)

AT10008474T 2004-11-05 2005-11-03 4-hydroxybenzomorphane ATE557006T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US62534804P	2004-11-05	2004-11-05

Publications (1)

Publication Number	Publication Date
ATE557006T1 true ATE557006T1 (de)	2012-05-15

Family

ID=36128632

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT10008474T ATE557006T1 (de)	2004-11-05	2005-11-03	4-hydroxybenzomorphane

Country Status (20)

Country	Link
US (7)	US7262298B2 (de)
EP (2)	EP1817291A1 (de)
JP (3)	JP5198067B2 (de)
KR (1)	KR101115841B1 (de)
CN (1)	CN101090891B (de)
AT (1)	ATE557006T1 (de)
AU (1)	AU2005304950B2 (de)
BR (1)	BRPI0517091B8 (de)
CA (1)	CA2587074C (de)
CY (1)	CY1112946T1 (de)
DK (1)	DK2251330T3 (de)
ES (1)	ES2387737T3 (de)
IL (1)	IL182983A (de)
MX (1)	MX2007005389A (de)
NO (1)	NO340204B1 (de)
PL (1)	PL2251330T3 (de)
PT (1)	PT2251330E (de)
RU (2)	RU2415131C2 (de)
SI (1)	SI2251330T1 (de)
WO (1)	WO2006052710A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1359146B1 (de) *	2000-10-31	2008-04-09	Rensselaer Polytechnic Institute	4-arylpiperidine als opioidrezeptorbindende agenzien
EP1817291A1 (de) *	2004-11-05	2007-08-15	Rensselaer Polytechnic Institute	4-hydroxybenzomorphane
ES2422579T3 (es)	2005-07-21	2013-09-12	Rensselaer Polytech Inst	2,6-Metano-3-benzazocinas 8-carboxamido sustituidas y 3-carboxamido morfanos sustituidos como ligandos de los receptores opioides
AU2008207580B2 (en)	2007-05-04	2011-04-14	SpecGx LLC	Improved process for the preparation of 6-alpha-hydroxy-N-alkylated opiates
WO2009012005A1 (en)	2007-07-17	2009-01-22	Mallinckrodt Inc.	Preparation of n-alkylated opiates by reductive amination
AU2008286979B2 (en)	2007-08-09	2013-03-28	Rensselaer Polytechnic Institute	Quaternary opioid carboxamides
US8269006B2 (en)	2008-09-30	2012-09-18	Mallinckrodt Llc	Processes for the selective amination of ketomorphinans
US8946419B2 (en)	2009-02-23	2015-02-03	Mallinckrodt Llc	(+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
EP2408303A4 (de) *	2009-03-19	2012-07-25	Alkermes Inc	Morphinanderivate mit hoher oraler biologischer verfügbarkeit
WO2010118274A1 (en) *	2009-04-09	2010-10-14	Mallinckrodt Inc.	Preparation of 6-keto, 3-alkoxy morphinans
CN102459274B (zh)	2009-06-11	2015-07-15	马林克罗特有限公司	6-酮基去甲吗啡喃通过催化氢转移的还原胺化
CN102803267A (zh)	2009-06-11	2012-11-28	马林克罗特有限公司	通过催化氢转移的6-α-氨基N-取代的吗啡喃的制备
AU2010326676B2 (en) *	2009-12-04	2013-03-14	Alkermes Pharma Ireland Limited	Morphinan derivatives for the treatment of drug overdose
JP5964809B2 (ja)	2010-03-22	2016-08-03	レンセラールポリテクニックインスティチュート	オピオイド受容体リガンドとしてのカルボキサミド基を含有するモルヒネ誘導体
WO2011137086A1 (en) *	2010-04-29	2011-11-03	Mallinckrodt Llc	Preparation of saturated ketone morphinan compounds having low metal content
JP5728084B2 (ja)	2010-07-08	2015-06-03	アルカーメスファーマアイルランドリミテッド	置換モルフィナンの合成のための方法
PL3446565T3 (pl)	2010-08-23	2024-04-02	Alkermes Pharma Ireland Limited	Sposoby leczenia przyrostu masy ciała wywołanego lekami przeciwpsychotycznymi
US9029543B2 (en)	2011-04-05	2015-05-12	Alkermes, Inc.	Process for the synthesis of quaternary amine compounds
MX2013013634A (es)	2011-06-09	2013-12-12	Mallinckrodt Llc	Aminacion reductiva de 6-ceto-morfinanos por transfrencia catalitica de hidrogeno.
RS56181B1 (sr)	2011-06-29	2017-11-30	Alkermes Inc	Periferno delujuća opioidna jedinjenja
CN103917543A (zh)	2011-09-08	2014-07-09	马林克罗特有限公司	在不分离中间体的情况下制备生物碱
PL3153171T3 (pl)	2011-12-15	2019-02-28	Alkermes Pharma Ireland Limited	Samidorfan (alks 33) w połączeniu z buprenorfiną do leczenia zaburzeń depresyjnych
US9211293B2 (en)	2011-12-15	2015-12-15	Alkermes Pharma Ireland Limited	Opioid agonist antagonist combinations
US9656961B2 (en)	2013-05-24	2017-05-23	Alkermes Pharma Ireland Limited	Methods for treating depressive symptoms
WO2014190270A1 (en)	2013-05-24	2014-11-27	Alkermes Pharma Ireland Limited	Morphan and morphinan analogues, and methods of use
EP3590511A4 (de) *	2017-03-02	2020-09-02	Sanwa Kagaku Kenkyusho Co., Ltd	Therapeutikum für alkoholmissbrauch
CN107089948B (zh) *	2017-04-28	2020-07-17	云南大学	吗吩衍生物及其制备方法和应用
CN111978252A (zh) *	2019-05-21	2020-11-24	复旦大学	手性苯并吗吩烷类衍生物及其制备方法和在药学上的应用
TW202140009A (zh) *	2020-02-13	2021-11-01	大陸商上海翰森生物醫藥科技有限公司	３－甲醯胺基－４－羥基納曲酮氘代衍生物、其製備方法及其在醫藥上的應用
CN111205151B (zh) *	2020-02-29	2021-03-05	深圳市祥根生物科技有限公司	一种布洛芬杂质i的环保制备方法
EP4243768A1 (de)	2020-11-12	2023-09-20	Alkermes Pharma Ireland Limited	Mehrschichttablette mit sofortiger freisetzung
CN114621238B (zh) *	2020-12-10	2026-02-03	鲁南制药集团股份有限公司	一种制备纳呋拉啡的方法
KR102663533B1 (ko) *	2021-11-09	2024-05-08	백미선	레이저 치료기기용 온냉각장치

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3957793A (en)	1974-09-20	1976-05-18	Sterling Drug Inc.	Hydroxyiminobenzazocines
US4032529A (en)	1974-09-20	1977-06-28	Sterling Drug Inc.	Aminomethanobenzazocine intermediates
SU635868A3 (ru) *	1974-11-12	1978-11-30	Бристол Мейерз Компани (Фирма)	Способ получени морфиновых производных или их солей
US4205171A (en)	1976-01-12	1980-05-27	Sterling Drug Inc.	Aminomethanobenzazocines and nitromethanobenzazocines
US4373139A (en)	1979-04-30	1983-02-08	Motorola, Inc.	Detectors
US4649200A (en)	1986-05-08	1987-03-10	Regents Of The University Of Minnesota	Substituted pyrroles with opioid receptor activity
EP0632041A1 (de)	1993-07-01	1995-01-04	Katholieke Universiteit Nijmegen	Neue Morphin Derivate mit verbesserten analgetischen und narkotischen Eigenschaften
ES2188888T3 (es)	1996-01-10	2003-07-01	Glaxosmithkline Spa	Derivados morfinoides 8ii) con condensados con heterociclos.
EP1359146B1 (de) *	2000-10-31	2008-04-09	Rensselaer Polytechnic Institute	4-arylpiperidine als opioidrezeptorbindende agenzien
AU2003281060A1 (en)	2002-07-16	2004-02-02	Rensselaer Polytechnic Institute	Process for conversion of phenols to carboxamides via the succinimide esters
EP1817291A1 (de) *	2004-11-05	2007-08-15	Rensselaer Polytechnic Institute	4-hydroxybenzomorphane

2005
- 2005-11-03 EP EP05851351A patent/EP1817291A1/de not_active Withdrawn
- 2005-11-03 SI SI200531549T patent/SI2251330T1/sl unknown
- 2005-11-03 CN CN2005800451698A patent/CN101090891B/zh not_active Expired - Lifetime
- 2005-11-03 AU AU2005304950A patent/AU2005304950B2/en not_active Expired
- 2005-11-03 PL PL10008474T patent/PL2251330T3/pl unknown
- 2005-11-03 RU RU2007120759/04A patent/RU2415131C2/ru active
- 2005-11-03 PT PT10008474T patent/PT2251330E/pt unknown
- 2005-11-03 BR BRPI0517091A patent/BRPI0517091B8/pt active IP Right Grant
- 2005-11-03 KR KR1020077012582A patent/KR101115841B1/ko not_active Expired - Lifetime
- 2005-11-03 CA CA2587074A patent/CA2587074C/en not_active Expired - Lifetime
- 2005-11-03 RU RU2010147915/04A patent/RU2480455C2/ru active
- 2005-11-03 AT AT10008474T patent/ATE557006T1/de active
- 2005-11-03 US US11/266,651 patent/US7262298B2/en not_active Expired - Lifetime
- 2005-11-03 EP EP10008474A patent/EP2251330B1/de not_active Expired - Lifetime
- 2005-11-03 DK DK10008474.8T patent/DK2251330T3/da active
- 2005-11-03 JP JP2007540055A patent/JP5198067B2/ja not_active Expired - Lifetime
- 2005-11-03 ES ES10008474T patent/ES2387737T3/es not_active Expired - Lifetime
- 2005-11-03 WO PCT/US2005/039911 patent/WO2006052710A1/en not_active Ceased
- 2005-11-03 MX MX2007005389A patent/MX2007005389A/es active IP Right Grant
2007
- 2007-05-03 IL IL182983A patent/IL182983A/en active IP Right Grant
- 2007-06-04 NO NO20072839A patent/NO340204B1/no unknown
- 2007-06-08 US US11/760,039 patent/US8680112B2/en active Active
2012
- 2012-07-31 CY CY20121100677T patent/CY1112946T1/el unknown
- 2012-11-22 JP JP2012256445A patent/JP6058981B2/ja not_active Expired - Lifetime
2013
- 2013-04-15 US US13/862,975 patent/US20130231361A1/en not_active Abandoned
2014
- 2014-01-31 US US14/169,305 patent/US8802655B2/en not_active Expired - Lifetime
- 2014-07-02 US US14/321,885 patent/US20150011768A1/en not_active Abandoned
2015
- 2015-04-27 US US14/697,013 patent/US20160075658A1/en not_active Abandoned
- 2015-08-12 JP JP2015159733A patent/JP2016020364A/ja active Pending
2023
- 2023-04-17 US US18/301,336 patent/US20240092740A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US7262298B2 (en)	2007-08-28
WO2006052710A1 (en)	2006-05-18
DK2251330T3 (da)	2012-08-06
RU2480455C2 (ru)	2013-04-27
EP2251330A1 (de)	2010-11-17
AU2005304950B2 (en)	2010-12-09
CN101090891B (zh)	2012-08-01
NO340204B1 (no)	2017-03-20
JP6058981B2 (ja)	2017-01-11
PL2251330T3 (pl)	2012-12-31
US8802655B2 (en)	2014-08-12
JP2016020364A (ja)	2016-02-04
CY1112946T1 (el)	2016-04-13
US8680112B2 (en)	2014-03-25
US20150011768A1 (en)	2015-01-08
IL182983A (en)	2012-06-28
ES2387737T3 (es)	2012-10-01
CA2587074A1 (en)	2006-05-18
MX2007005389A (es)	2007-12-07
RU2007120759A (ru)	2008-12-10
KR101115841B1 (ko)	2012-03-09
PT2251330E (pt)	2012-07-20
CN101090891A (zh)	2007-12-19
BRPI0517091B8 (pt)	2021-05-25
US20160075658A1 (en)	2016-03-17
JP2008519035A (ja)	2008-06-05
US20140148475A1 (en)	2014-05-29
US20070238748A1 (en)	2007-10-11
EP1817291A1 (de)	2007-08-15
BRPI0517091A (pt)	2008-09-30
US20060111384A1 (en)	2006-05-25
JP2013067636A (ja)	2013-04-18
US20240092740A1 (en)	2024-03-21
SI2251330T1 (sl)	2012-09-28
IL182983A0 (en)	2007-08-19
NO20072839L (no)	2007-08-03
CA2587074C (en)	2012-09-04
RU2415131C2 (ru)	2011-03-27
AU2005304950A1 (en)	2006-05-18
JP5198067B2 (ja)	2013-05-15
KR20070085723A (ko)	2007-08-27
BRPI0517091B1 (pt)	2019-10-08
RU2010147915A (ru)	2012-05-27
EP2251330B1 (de)	2012-05-09
US20130231361A1 (en)	2013-09-05

Publication	Publication Date	Title
DK2251330T3 (da)	2012-08-06	4-Hydroxybenzomorphaner
EP1900207A4 (de)	2010-02-10	Erzeugen standardisierter playlists und aufrechterhaltung von kohärenz
NO20052739D0 (no)	2005-06-07	CCR5-antagonister som medikamenter
GB0409558D0 (en)	2004-06-02	Particulate emulsifiers,emulsions and uses thereof
DE602005027567D1 (de)	2011-06-01	1-aza-bicycloä3.3.1ünonane
ITTO20020157A0 (it)	2002-02-25	Macchina depallettizzatrice.
ITRM20040607A1 (it)	2005-03-15	Analoghi della dermorfina ad attivita' analgesica.
NO20023948D0 (no)	2002-08-20	Selvlukkende kork
NO20052680D0 (no)	2005-06-03	Forbedringsmiddel inneholdende brennstoff.
ITBO20040403A1 (it)	2004-09-25	Riduttore di velocita', particolarmente per estrusori, e simili
EP1556022A4 (de)	2010-03-10	WûSSRIGE PHARMAZEUTISCHE 2,6-DIISOPROPYLPHENOL-ZUSAMMENSETZUNGEN
ES1051272Y (es)	2002-11-01	Peonza multiplicable.
BR0300829B1 (pt)	2011-10-04	carburador.
ES1049094Y (es)	2002-03-16	Dispositivo para la formacion de chaflanes en encofrados.
ITGE20030111A1 (it)	2005-06-25	Anta, in particolare per armadi e simili.
ITPD20030307A1 (it)	2005-06-24	Slamatore con bloccaggio dell'amo
ITRC20050012A1 (it)	2005-12-01	"palmira la bottiglia che attira".
ITMI20030317A1 (it)	2004-08-22	Terapia combinata comprendente un derivato dell'indolopirrolocarbazolo ed un altro agente antitumorale.
ITRM20040183A1 (it)	2004-07-09	Miscela erboristica e fitofarmaco comprendente la stessa.
ITMO990010V0 (it)	1999-02-25	Anta sagomata per mobili e simili.
ES1053317Y (es)	2003-07-16	Util colgador para sombrillas y otros.
FI5841U1 (fi)	2003-07-03	Porttivahti
ES1051463Y (es)	2002-11-16	Plantilla anatomico-ortopedica inyectada.
ITNA20020031V0 (it)	2002-06-14	Contenitore di sicurezza per aghi denominati butterfly.
SE0202559D0 (sv)	2002-08-30	Broms för rollatorer o.d.